BioGaia

Regulatory Filings • Sep 20, 2007

Press Release 20 September 2007

BioGaia signs agreement for probiotic oral health products in Scandinavia

BioGaia has signed an agreement with Sunstar Suisse SA, which gives the company exclusive rights to distribute BioGaia´s probiotic oral health products in Sweden, Norway and Denmark.

Sunstar Suisse already distributes BioGaia´s oral health products in Germany, France, Italy and Spain and also has an option to launch the products in a large number of markets globally.

The goal in Sweden, Norway and Denmark is to sell the products through pharmacies and dental clinics. The products will be sold under Sunstar´s brand G.U.M. Periobalance with a clear BioGaia profile.

"The Scandinavian agreement with Sunstar means that the positive collaboration with Sunstar will be expanded to also include BioGaia´s home market. In the long term, we predict that sales of the oral health products in Scandinavia will be significant. We are convinced that Sunstar, with their long experience of working close to dental clinics and pharmacies in Scandinavia, are an ideal partner for us," says Peter Rothschild, President, BioGaia AB.

Sunstar is one of the world´s largest companies in the area of oral health. Sunstar´s products are sold in most global markets under brands such as G.U.M. and Butler. In Europe G.U.M. products are sold in a total of 24 countries. Sunstar was founded in Japan in 1932 and has 3,200 employees. In the last financial year Sunstar´s turnover was approximately 1 billion USD.

Latest press releases from BioGaia:

2007-09-06	BioGaia signs agreement in South America
2007-08-23	Interim report 1 January – 30 June 2007
2007-08-16	BioGaia signs further agreement with Ferring Pharmaceuticals

For additional information contact:

Peter Rothschild, President, telephone: +46 8 - 555 293 00, Jan Annwall, Executive vice President, telephone: +46 8 - 555 293 00

----------------------------------------------------------------------------------------------------------------------------------------------- BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list of the Nordic Stock Exchange in Stockholm.

www.biogaia.com